Sobi

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40019800

Informations générales

Localisation

Sweden

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

24/04/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon FY2029

Statut

Targets set

Classification

1.5°C

Année cible

FY2029

Progression vers l'objectif0%
2015 (année de référence)FY2029
Description complète des objectifs

Near-Term Targets: Swedish Orphan Biovitrum AB (Sobi) commits to reduce absolute scope 1 and 2 GHG emissions 37.8% by FY2029 from a FY2023 base year. Swedish Orphan Biovitrum AB (Sobi) also commits that 65% of its suppliers by spend covering purchased goods and services and upstream transportation and distribution, will have science-based targets by FY2029.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

SE0000872095

LEI

549300124Y3MQI87PT35

Source : Science Based Targets initiative | Données publiques